What drove Thermo Fisher's revenue growth in Q4 2024?

Thermo Fisher's revenue growth in Q4 2024 was driven by several key factors:

1. **Strategic Acquisitions**: The company's ongoing strategy of acquiring businesses that augment its product portfolio has contributed significantly to its growth. Recent acquisitions, such as the $3.1 billion purchase of Olink Holdings, are expected to deliver revenue synergies and cost efficiencies.
2. **End Market Growth**: Within the pharmaceutical and biotech end markets, Thermo Fisher's biosciences and bioproduction businesses have expanded capacity to meet global vaccine manufacturing demands. Despite the runoff of vaccines and therapy revenues, the research and safety market channels and clinical research business have contributed to growth.
3. **Electron Microscopy Business**: The company's electron microscopy business has seen strong growth, contributing to overall revenue expansion. This growth is part of a broader trend of increased demand for advanced research tools and diagnostics in various market segments.
4. **International Performance**: Thermo Fisher's international performance, particularly in regions like Asia Pacific, has been a growth driver. The company has benefited from steady user growth across all regions, with notable contributions from its social media platforms like Instagram, WhatsApp, and Messenger.

These factors, combined with robust operational performance and market positioning, have supported Thermo Fisher's revenue growth in Q4 2024.